 FDx Advisors Inc. bought a new position in Dicerna Pharmaceuticals Inc NASDAQ:DRNA during the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 30,000 shares of the biopharmaceutical companys stock, valued at approximately 38,000. A number of other hedge funds and other institutional investors have also recently bought and ... 